Other
Corticosteroids
0
Pipeline Programs↗
8
Active Trials↗
6
Companies Involved↗
Corticosteroids is an early-stage landscape with 0 programs across 6 companies. The most active players are Merck & Co., Boehringer Ingelheim, Biogen.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
59
clinical trials
Completed31 · 53%
Terminated10 · 17%
Unknown status8 · 14%
Recruiting4 · 7%
Not yet recruiting2 · 3%
Withdrawn2 · 3%
Other2 · 3%
Clinical Trials
Trial Activity
59 trials
Benefit of a Flash Dose of Corticosteroids in Digestive Surgical Oncology: a Randomized, Double Blind, Placebo-controlled Trial
Active, not recruiting·—·Phase 3·NCT03875690·1,200 enrolled
Cost-effectiveness Analysis of Three Corticosteroids in ILDs
Completed·—·N/A·NCT04982809·107 enrolled
Corticosteroids in Community Acquired Pneumonea
Completed·—·N/A·NCT01228110·80 enrolled
Page 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)